Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Constellium
CSTM
$3.99B
| $318K | ﹤0.01% |
61,215
+55,643
| +999% | +$320K |
|
|
JKS
5127
CALL
JinkoSolar
JKS
$891M
| $318K | ﹤0.01% |
15,200
-18,600
| -55% | -$400K |
|
5128
Towne Bank
TOWN
$3.42B
| $318K | ﹤0.01% |
+16,580
| New | +$307K |
|
|
GPX
5129
DELISTED
GP Strategies Corp.
GPX
| $318K | ﹤0.01% |
+11,593
| New | +$282K |
|
5130
LCNB Corp
LCNB
$283M
| $317K | ﹤0.01% |
+19,735
| New | +$320K |
|
5131
Direxion Daily Technology Bear 3x ETF
TECS
$55.6M
| – | – |
0
| – | – |
|
|
LGF
5132
PUT
DELISTED
Lions Gate Entertainment
LGF
| $317K | ﹤0.01% |
14,500
-12,200
| -46% | -$291K |
|
|
OREX
5133
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $317K | ﹤0.01% |
56,350
-4,523
| -7% | -$58.7K |
|
5134
PUT
EQT Corp
EQT
$32.3B
| $316K | ﹤0.01% |
8,634
-22,779
| -73% | -$729K |
|
5135
CALL
El Pollo Loco
LOCO
$462M
| $316K | ﹤0.01% |
23,700
-19,100
| -45% | -$240K |
|
|
FLXN
5136
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $316K | ﹤0.01% |
34,383
+7,272
| +27% | +$88.2K |
|
|
ZBIO
5137
DELISTED
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
| $316K | ﹤0.01% |
+4,367
| New | +$324K |
|
|
AEPI
5138
DELISTED
AEP Industries Inc
AEPI
| $316K | ﹤0.01% |
+4,792
| New | +$362K |
|
|
OSIR
5139
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $316K | ﹤0.01% |
55,334
+8,363
| +18% | +$58.4K |
|
|
EXAS
5140
DELISTED
Exact Sciences
EXAS
| $315K | ﹤0.01% |
46,772
-168,666
| -78% | -$1.08M |
|
5141
MacroGenics
MGNX
$257M
| $315K | ﹤0.01% |
16,794
+9,956
| +146% | +$190K |
|
5142
CALL
Xerox
XRX
$425M
| $315K | ﹤0.01% |
10,702
-21,328
| -67% | -$550K |
|
|
WCG
5143
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $315K | ﹤0.01% |
3,400
+1,900
| +127% | +$158K |
|
|
SHLDW
5144
DELISTED
Sears Holdings Corporation - Warrant
SHLDW
| $315K | ﹤0.01% |
+71,000
| New | +$458K |
|
5145
PUT
Boston Scientific
BSX
$71.5B
| $314K | ﹤0.01% |
16,700
-81,200
| -83% | -$1.43M |
|
|
LIOX
5146
DELISTED
Lionbridge Technologies
LIOX
| $314K | ﹤0.01% |
62,027
+35,229
| +131% | +$161K |
|
5147
Fate Therapeutics
FATE
$326M
| $313K | ﹤0.01% |
173,924
+147,233
| +552% | +$303K |
|
|
TRUE
5148
DELISTED
TrueCar
TRUE
| $313K | ﹤0.01% |
55,994
-3,938
| -7% | -$23.8K |
|
5149
PUT
Viavi Solutions
VIAV
$9.66B
| $313K | ﹤0.01% |
45,600
-300
| -0.7% | -$1.8K |
|
|
PHX
5150
DELISTED
PHX Minerals
PHX
| $312K | ﹤0.01% |
18,002
+6,386
| +55% | +$98.3K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.